Biomedicines (Feb 2024)

Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability

  • Georgia-Andriana Georgopoulou,
  • Marios Papasotiriou,
  • Pinelopi Bosgana,
  • Anne-Lise de Lastic,
  • Eleni-Evangelia Koufou,
  • Evangelos Papachristou,
  • Dimitrios S. Goumenos,
  • Periklis Davlouros,
  • Eleni Kourea,
  • Vasiliki Zolota,
  • Konstantinos Thomopoulos,
  • Athanasia Mouzaki,
  • Stelios F. Assimakopoulos

DOI
https://doi.org/10.3390/biomedicines12020368
Journal volume & issue
Vol. 12, no. 2
p. 368

Abstract

Read online

Background: Systemic inflammation in chronic kidney disease (CKD) is associated (as a cause or effect) with intestinal barrier dysfunction and increased gut permeability, with mechanisms not yet fully understood. This study investigated different parameters of the intestinal barrier in CKD patients, especially tight junction (TJ) proteins and their possible association with systemic endotoxemia and inflammation. Methods: Thirty-three patients with stage I–IV CKD (n = 17) or end-stage kidney disease (ESKD) (n = 16) and 11 healthy controls underwent duodenal biopsy. Samples were examined histologically, the presence of CD3+ T-lymphocytes and the expression of occludin and claudin-1 in the intestinal epithelium was evaluated by means of immunohistochemistry, circulating endotoxin concentrations were determined by means of ELISA and the concentrations of the cytokines IL-1β, IL-6, IL-8, IL-10 and TNF-α in serum were measured using flow cytometry. Results: Patients with stage I–IV CKD or ESKD had significantly higher serum endotoxin, IL-6, IL-8 and IL-10 levels compared to controls. Intestinal occludin and claudin-1 were significantly decreased, and their expression was inversely correlated with systemic endotoxemia. Regarding occludin, a specific expression pattern was observed, with a gradually increasing loss of its expression from the crypt to the tip of the villi. Conclusion: The expression of occludin and claudin-1 in enterocytes is significantly reduced in patients with CKD, contributing to systemic endotoxemia and inflammatory responses in these patients.

Keywords